MEDCAPTAIN

Medcaptain Medical dipped another 5% today after a 43% plunge on its debut, pressured by a new China device procurement round. The stock opened flat at HKD 9.000, hitting the intraday high before falling to a low of HKD 8.555 in a single downtrend. Volume was thin at 68,400 shares, with market cap around HKD 4.6 billion. Q1 2026 revenue grew 26% YoY to HKD 478.8 million, but net profit flipped to a loss of HKD 3.5 million with EPS at -HKD 0.007 and net margin -0.73%. The current price of HKD 8.555 sits 21.51% below the 52-week high of HKD 10.9 and below both the MA20 and MA60 (HKD 8.966), with a YTD decline of 2.78%. A 7% rebound on Monday, however, signaled short-term buying interest.

Medcaptain Medical closed at HKD 9.05 today, falling 5.3% from the previous close of HKD 9.56, in a single-sided downward trend. The stock opened at HKD 9.415, which also marked the intraday high of HKD 9.41, then weakened continuously, accelerating in the afternoon to touch the day's low of HKD 9.05, with turnover of HKD 9.88 million. After plunging 43% on its debut and staging a brief rebound, the stock turned lower again today, breaking below its 20-day moving average of HKD 9.137, and is now 17% below the 52-week high of HKD 10.9 set last Friday. Sentiment has been cautious toward Chinese healthcare stocks, and despite a 5% bounce the day after the debut sell-off, the stock has failed to stabilize. Meanwhile, Q1 2026 results showed revenue up 26% year-on-year to HKD 479 million, but a net loss of HKD 3.5 million compared to a profit a year earlier, with EPS at -HKD 0.007 and net margin of -0.7%, weighing on the stock. The stock trades at a P/E of 105.6x and P/B of 2.28x, with a market cap of HKD 4.87 billion and a meager turnover rate of 0.22%. That said, the company's life support and minimally invasive intervention product lines could provide a correction buffer if profit improves in subsequent quarters.

2041.HK opened at 8.8, dipped to an intraday low of 8.99, then rallied to a high of 9.945 in the afternoon session, closing at 9.6 for a 9.1% gain from the previous close of 8.8, with a 10.7% range, forming a rebound pattern. The move was driven by bargain hunting after a 43% debut-day selloff, with media coverage on Medcaptain's bounce and governance filings, on total turnover of ~HK$30M. The stock is still well below its 52-week high (data unavailable) and about 2.3% above the day's average of 9.386, though the limited intraday rally suggests caution on follow-through.